Miist Therapeutics, a physics-based developer of inhaled medicines, today announced $7M in seed funding from investors ...

Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] Dr Ma ...

Inhalers for COPD provide steroids, bronchodilators, or combination drugs. The three types differ in the mechanism by which the medication is inhaled and have different instructions for use.

He dropped out of the university to work on this problem, creating Miist Therapeutics, attracting Jeff Schuster (pictured left), a physicist who has dozens of patents for developing inhaled medicines, ...

ALAMEDA, Calif., February 05, 2025--(BUSINESS WIRE)--Miist Therapeutics, a physics-based developer of inhaled medicines, today announced $7M in seed funding from investors including Refactor ...

a physics-based developer of inhaled medicines, today announced $7M in seed funding from investors including Refactor Capital, 1517 Fund, Freeflow Ventures, Entrepreneur First, and California ...